Standard Biotools (LAB) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026)
Standard Biotools (LAB) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.93 Bn | 193.33 Bn | 7.27 Bn | 12.44% |
| 2 | Stryker | 128.56 Bn | 125.08 Bn | 4.50 Bn | 6.92% |
| 3 | Medtronic | 119.26 Bn | 110.04 Bn | 6.41 Bn | 8.48% |
| 4 | Boston Scientific | 73.35 Bn | 72.81 Bn | 3.85 Bn | 19.21% |
| 5 | Edwards Lifesciences | 52.06 Bn | 47.81 Bn | 1.35 Bn | 6.67% |
| 6 | Dexcom | 34.55 Bn | 32.61 Bn | 830.00 Mn | 8.23% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 6.21% |
| 8 | Koninklijke Philips | 26.39 Bn | 23.07 Bn | 4.55 Bn | -1.40% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 5.69% |
| 10 | Standard Biotools | 254.39 Mn | -222.33 Mn | 10.54 Mn | -32.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -32.53% |
| Mar 31, 2026 | -60.77% |
| Dec 31, 2025 | -15.37% |
| Sep 30, 2025 | -50.60% |
| Jun 30, 2025 | -46.73% |
| Mar 31, 2025 | -2.66% |
| Dec 31, 2024 | -5.84% |
| Sep 30, 2024 | 71.09% |
| Jun 30, 2024 | 73.60% |
| Mar 31, 2024 | 79.13% |
| Dec 31, 2023 | -5.71% |
| Sep 30, 2023 | -7.70% |
| Jun 30, 2023 | -10.09% |
| Mar 31, 2023 | -9.74% |
| Dec 31, 2022 | -8.50% |
| Sep 30, 2022 | -8.06% |
| Jun 30, 2022 | -1.60% |
| Mar 31, 2022 | 16.46% |
| Dec 31, 2021 | 59.91% |
| Sep 30, 2021 | 283.92% |